Safety and efficacy of combining genotype-guided irinotecan (Iri) with 5FU, leucovorin (LV), oxaliplatin (Ox), and docetaxel (Tax) (gFOLFOXIRITAX): The I-FLOAT phase 1 dose-escalation study for advanced upper GI cancers
Paydary, Koosha, Desgardin, Aurelie, Liao, Chih-Yi, Shergill, Ardaman, Reizine, Natalie Marie, Moya, Stephanie, Peterson, Bryan, Reyes, Katherine, Robinzine, Chanelle, Martinez-Caro Aguado, Belen, Racette, Christine, Ignatiev, Elena, Neerukonda, Anu Radha, Ji, Yuan, Polite, Blase N., Catenacci, Daniel V.T.
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article